Impact of the COVID-19 Pandemic on the Treatment of Cancer Patients at a Hospital in Peru.

IF 2.5 4区医学 Q3 ONCOLOGY

Cancer Control Pub Date : 2024-01-01 DOI:10.1177/10732748241276616

Leny Bravo, Karla Vizcarra, Jenny Zavaleta, Kevin J Paez, Zaida Morante, Abel Limache-García, César H Saravia

{"title":"Impact of the COVID-19 Pandemic on the Treatment of Cancer Patients at a Hospital in Peru.","authors":"Leny Bravo, Karla Vizcarra, Jenny Zavaleta, Kevin J Paez, Zaida Morante, Abel Limache-García, César H Saravia","doi":"10.1177/10732748241276616","DOIUrl":null,"url":null,"abstract":"Background: The appearance of the new coronavirus, SARS-CoV-2, in Wuhan - China, in 2019 led to the declaration of a COVID-19 pandemic by the World Health Organization. Peru confirmed its first case on March 6, 2020, prompting a significant change in medical care.Purpose: Our objective was to determine the impact of the COVID-19 pandemic on cancer treatment in Peru.Methods: A retrospective analysis of hospital data from the National Institute of Neoplastic Diseases revealed substantial decreases in oncological treatments in 2020 compared to 2019.Results: Oncological treatments involving bone marrow transplantation had a greater impact between the months of April and September, at -100% (p=0.003). However, treatments involving surgery in April (-95% [p≤0.001]), radiotherapy in May (-76% [p=0.002]) and chemotherapy in June (-71% [p≤0.001]) also showed significant impacts. Comparative analysis with international data revealed similar trends in cancer care interruptions in different countries. However, variations in the magnitude of the impact were observed, influenced by regional health policies and the severity of the pandemic.Conclusions: The findings underscore the challenges cancer care providers face during public health crises, requiring adaptive strategies to ensure continued access to essential treatments. Addressing these challenges requires comprehensive public health responses to mitigate the impact of future crises on cancer care systems.","PeriodicalId":49093,"journal":{"name":"Cancer Control","volume":null,"pages":null},"PeriodicalIF":2.5000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11331466/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Control","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/10732748241276616","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: The appearance of the new coronavirus, SARS-CoV-2, in Wuhan - China, in 2019 led to the declaration of a COVID-19 pandemic by the World Health Organization. Peru confirmed its first case on March 6, 2020, prompting a significant change in medical care.

Purpose: Our objective was to determine the impact of the COVID-19 pandemic on cancer treatment in Peru.

Methods: A retrospective analysis of hospital data from the National Institute of Neoplastic Diseases revealed substantial decreases in oncological treatments in 2020 compared to 2019.

Results: Oncological treatments involving bone marrow transplantation had a greater impact between the months of April and September, at -100% (p=0.003). However, treatments involving surgery in April (-95% [p≤0.001]), radiotherapy in May (-76% [p=0.002]) and chemotherapy in June (-71% [p≤0.001]) also showed significant impacts. Comparative analysis with international data revealed similar trends in cancer care interruptions in different countries. However, variations in the magnitude of the impact were observed, influenced by regional health policies and the severity of the pandemic.

Conclusions: The findings underscore the challenges cancer care providers face during public health crises, requiring adaptive strategies to ensure continued access to essential treatments. Addressing these challenges requires comprehensive public health responses to mitigate the impact of future crises on cancer care systems.

查看原文本刊更多论文

COVID-19 大流行对秘鲁一家医院癌症患者治疗的影响。

背景：2019年在中国武汉出现的新型冠状病毒SARS-CoV-2导致世界卫生组织宣布COVID-19大流行。秘鲁于 2020 年 3 月 6 日确诊了首例病例，促使医疗服务发生了重大变化。目的：我们的目标是确定 COVID-19 大流行对秘鲁癌症治疗的影响：对国家肿瘤疾病研究所提供的医院数据进行回顾性分析后发现，与 2019 年相比，2020 年的肿瘤治疗大幅减少：涉及骨髓移植的肿瘤治疗在4月至9月间影响较大，为-100%（p=0.003）。然而，4月份的手术治疗（-95% [p≤0.001]）、5月份的放疗（-76% [p=0.002]）和6月份的化疗（-71% [p≤0.001]）也有显著影响。与国际数据的比较分析表明，不同国家的癌症治疗中断趋势相似。然而，受地区卫生政策和疫情严重程度的影响，影响程度也存在差异：研究结果强调了癌症治疗提供者在公共卫生危机期间所面临的挑战，需要采取适应性策略以确保持续获得基本治疗。应对这些挑战需要采取全面的公共卫生应对措施，以减轻未来危机对癌症治疗系统的影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cancer Control ONCOLOGY-

CiteScore

3.80

自引率

0.00%

发文量

148

审稿时长

>12 weeks

期刊介绍： Cancer Control is a JCR-ranked, peer-reviewed open access journal whose mission is to advance the prevention, detection, diagnosis, treatment, and palliative care of cancer by enabling researchers, doctors, policymakers, and other healthcare professionals to freely share research along the cancer control continuum. Our vision is a world where gold-standard cancer care is the norm, not the exception.

文献相关原料

公司名称	产品信息	采购帮参考价格